CompletedPhase 3NCT03790137
Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).
Studying Reflex epilepsy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Elizabeth Anne Thiele
- Principal Investigator
- Elizabeth Thiele, M.D., Ph.D., TLLPDirector, Pediatric Epilepsy Program
- Intervention
- Fenfluramine Hydrochloride(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 4-25 years · All sexes
- Timeline
- 2019 – 2024
Study locations (1)
- Massachusetts General Hospital, Boston, Massachusetts, United States
Collaborators
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03790137 on ClinicalTrials.govOther trials for Reflex epilepsy
Additional recruiting or active studies for the same condition.